Drugs / Airway Basal Stem Cells
last change Nov 2025 re-read 3 minutes ago

Airway Basal Stem Cells

Developed for
bronchiolitis
Investigated by
Regend Therapeutics · Shanghai Children's Hospital

Trials 1

20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07239895 Nov 2025 → Nov 2027 expected bronchiolitis Regend Therapeutics Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Airway Basal Stem Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT07239895 ↗